32,180 Alzheimer's and dementia studies in plain English, each scored out of 100.
A 2-year multi-domain lifestyle intervention among older adults was effective in preventing cerebrovascular events and also total CVD events among those who had history of CVD. 2 key findings →
Participants: 631 Evidence: high
Full summary, score breakdown and related studies → Original source
This systematic review suggests that CCT interventions could improve global cognitive function in patients with MCI. 5 key findings →
Design: systematic review Participants: 1,059 Evidence: high
Full summary, score breakdown and related studies → Original source
Vascular management takes place every 3-6 months or otherwise as specified by study physicians. 5 key findings →
Design: randomized controlled trial Participants: 1,200 Evidence: high
Full summary, score breakdown and related studies → Original source
Pain is inversely associated with cognitive function in older adults, but the effects of pain on cognitive decline are not fully clear. 1 key finding →
Design: randomized controlled trial Participants: 688 Evidence: high
Full summary, score breakdown and related studies → Original source
Adherence to the MeDi diet may reduce the risk of MCI and AD. 5 key findings →
Design: systematic review Evidence: high
Full summary, score breakdown and related studies → Original source
Cognitive impairment is a central non-motor symptom of Parkinson's disease (PD), and there are no established treatments. 4 key findings →
Design: meta-analysis Participants: 679 Evidence: high
Full summary, score breakdown and related studies → Original source
RS-tDCS is a safe and feasible rehabilitation modality for poststroke cognitive dysfunction. 3 key findings →
Evidence: high
Full summary, score breakdown and related studies → Original source
A total of 6321 participants (mean [SE] age, 56.1 [0.18] years at visit 1; n = 4077 women [57.8%]) were included. 3 key findings →
Design: cohort study Participants: 4,077 Evidence: moderate
Full summary, score breakdown and related studies → Original source
Aging is characterized by cognitive decline affecting daily functioning. 3 key findings →
Evidence: high
Full summary, score breakdown and related studies → Original source
Cohort studies suggest that the Mediterranean diet is associated with better global cognition in older adults, slower cognitive decline and lower risk of dementia. 5 key findings →
Design: cohort study Participants: 249,511 Evidence: moderate
Full summary, score breakdown and related studies → Original source
Since our cognitive training showed beneficial effects, it could be a promising method to prevent POCD. 1 key finding →
Participants: 37 Evidence: high
Full summary, score breakdown and related studies → Original source
The heterogeneous and multi-factorial nature of dementia requires the consideration of all health aspects when predicting the risk of its development and planning strategies for its prevention. 2 key findings →
Design: systematic review Evidence: high
Full summary, score breakdown and related studies → Original source
This systematic review demonstrated that adherence to the Mediterranean diet and other healthy dietary patterns in middle age can protect neurocognition later in life. 3 key findings →
Design: systematic review Evidence: high
Full summary, score breakdown and related studies → Original source
After 12 weeks, maintenance of executive functioning in the TG was found, yet no significant changes on circulating neurotrophins levels were identified. 3 key findings →
Participants: 16 Evidence: low
Full summary, score breakdown and related studies → Original source
In this cohort of French older adults, higher adherence to the French MIND diet was associated with a lower dementia risk and with preserved white matter microstructure. 5 key findings →
Design: longitudinal study Participants: 1,412 Evidence: moderate
Full summary, score breakdown and related studies → Original source
Overall, 68 studies were included in the meta-analyses. 2 key findings →
Design: systematic review Evidence: high
Full summary, score breakdown and related studies → Original source
In AD a clinical recommendation can be made for NEURO-AD TM system and for high-frequency rTMS over the left dorsolateral prefrontal cortex (DLPFC) as probably effective protocols (B-level of evidence) and for anodal tDCS over the left DLPFC as a possibly effective. 3 key findings →
Design: meta-analysis Evidence: high
Full summary, score breakdown and related studies → Original source
Our findings suggest that VR training is an effective treatment for both people with MCI and dementia. 5 key findings →
Design: meta-analysis Evidence: high
Full summary, score breakdown and related studies → Original source
Our analyses support that MNPI could improve the global cognition in older adults with MCI. 1 key finding →
Design: systematic review Evidence: high
Full summary, score breakdown and related studies → Original source
Free full text links and the Full text may need a subscription label come from Unpaywall, Europe PMC and OpenAlex records of free copies, checked 10 Oct 2026. A study with neither is unknown, not paywalled. Show only studies that are free to read
This is alzhub's own score. It is not an official metric, not an impact factor, and no journal, publisher or ranking body endorses it. We built it so that a reader who is not a scientist can tell a landmark trial from a conference abstract without having to already know the difference. Every point comes from one of 20 components, all of them printed on the study itself, so you can disagree with our arithmetic rather than having to trust the total.
Journals are placed in ordered tiers, never given a numeric impact factor — we could not verify current impact factors from a source we control, and an invented one would be worse than none. Tier 1 is the top-tier general journals (NEJM, The Lancet, JAMA, Nature, Science, Nature Medicine); tier 2 is the leading specialty journals; tier 3 is every other peer-reviewed journal. A separate part scores how much the journal's own papers are cited, which tells the tier-3 journals apart.
Two rules we don't bend. First, we never fill in a missing value: if a record does not state a sample size or a design, that component scores zero, and if we simply have no data for a part, such as a citation count, that part is left out and the study is scored on the parts we could check. The study card says which. Second, anything that is not a peer-reviewed article is capped at 16/100 and carries a warning chip — so a conference abstract or a company press release can never outrank a peer-reviewed paper, no matter how good it looks.
We rank a rigorous null result — a good trial showing that something does not work — above an early positive finding. Someone deciding whether to buy a supplement is served by that, and the rigour is already counted by the design and journal components.
The score is computed from the published data alone and is reproducible: the same file always yields the same numbers.
See the whole rubric drawn out → — four charts covering all 32,180 studies: how the scores are spread and where the cap bites, which of the 20 components the library is strong and weak on, which subjects rest on stronger evidence, and what kinds of study each subject is actually built from.
This is a large sample of the Alzheimer's literature, not an exhaustive index of it. It holds 32,180 records, built mostly from automated pulls of Europe PMC (66.5% of the library) and OpenAlex (15.8%), plus smaller pulls from PubMed, Crossref and medRxiv. If a study, a drug, or a finding isn't here, that is not evidence it doesn't exist in the literature — it may simply not have been pulled in yet.
1,045 records (3.2% of the library) are not peer-reviewed — 966 of those are preprints posted before any journal review, and the rest are conference abstracts, regulatory notices and reports. Every study card on this page states its status plainly, and the score above is capped for anything that isn't a peer-reviewed article.
See the full, machine-readable breakdown of this library's coverage →
Newest studies, as a dated timeline → Atom feed Where this research is being discussed: events
Last updated